(Q53581144)

English

Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty.

scientific article published on 22 December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty. (English)

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

1

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

Nick Freemantle

6

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

4

object named as

Mansoor Nasir

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

Alison P Coletta

2

object named as

Alison P Coletta

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

author name string

Ahmed Tageldien Abdellah

3

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

Neil Hobson

5

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

Andrew L Clark

7

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

publication date

22 December 2006

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

European Journal of Heart Failure

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

9

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

1

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

92-97

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

The late open artery hypothesis--a decade later

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Coronary intervention for persistent occlusion after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

The heart failure revascularisation trial (HEART): rationale, design and methodology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Clinical trials update from the American Heart Association meeting: Omega-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, OR

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Natriuretic peptides for heart failure. Fashionable? Useful? Necessary?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.12.001

21 January 2018

Identifiers

10.1016/J.EJHEART.2006.12.001

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17188569

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53581144&oldid=1739927467"